PT Kimia Farma Tbk (IDX:KAEF)

Market Cap	2.98T
Revenue (ttm)	9.09T
Net Income (ttm)	-710.51B
Shares Out	5.57B
EPS (ttm)	-127.64
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,782,900
Average Volume	2,034,320
Open	550.00
Previous Close	535.00
Day's Range	540.00 - 555.00
52-Week Range	324.00 - 905.00
Beta	1.43
RSI	58.82
Earnings Date	Oct 31, 2025

About PT Kimia Farma Tbk

PT Kimia Farma Tbk engages in the research, development, manufacture, and sale of pharmaceutical products in Indonesia and internationally. It offers generic drugs and ethical products; over-the-counter products and herbs; and cosmetic products. The company also provides integrated health clinic and medical laboratory services; operates a beauty clinic; and retails pharmaceutical products, as well as trades in and distributes drugs to pharmacies, hospital pharmacy installation, medical center, and drug store. In addition, it produces quinine sa...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1817
• Employees: 5,946
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: KAEF

Financial Performance

In 2024, PT Kimia Farma Tbk's revenue was 9.94 trillion, an increase of 0.68% compared to the previous year's 9.87 trillion. Losses were -842.27 billion, -57.12% less than in 2023.